Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Cancer Research

• Publication date

  1993-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7686816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.

  1992cited by this paper
• Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma.

  1992cited by this paper
• Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: Role of ICAM‐1 defined by antibody blocking and gene transfer

  1992cited by this paper
• Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.

  1992cited by this paper
• The eortc melanoma group exchange program: Evaluation of a multicenter monoclonal antibody study

  1991cited by this paper
• Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.

  1991cited by this paper
• Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.

  1991cited by this paper
• Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56).

  1991cited by this paper
• Phospholipase C treatment of certain human target cells reduces their susceptibility to NK lysis without affecting binding or sensitivity to lytic granules.

  1991cited by this paper
• Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity.

  1991cited by this paper
• Target lysis by human lak cells is critically dependent upon target binding properties, but LFA‐1, LFA‐3 AND ICAM‐1 are not the major adhesion ligands on targets

  1991cited by this paper
• Natural killer cells in cutaneous malignant melanoma

  1990cited by this paper
• A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection

  1990cited by this paper
• Integrins and other cell adhesion molecules

  1990cited by this paper
• Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders.

  1990cited by this paper
• Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.

  1990cited by this paper
• The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus.

  1990cited by this paper
• Adhesion receptors of the immune system

  1990cited by this paper
• De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.

  1989cited by this paper
• Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction

  1989cited by this paper
• Lysis of mycobacteria-infected monocytes by IL-2-activated killer cells: role of LFA-1.

  1989cited by this paper
• The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition.

  1989cited by this paper
• Purification of Murine IgG Monoclonal Antibodies by Precipitation with Caprylic Acid: Comparison with Other Methods of Purification

  1989cited by this paper
• Differential role of distinct determinants of intercellular adhesion molecule-1 in immunologic phenomena.

  1989cited by this paper
• Functional evidence that intercellular adhesion molecule‐1 (icam‐1) is a ligand for lfa‐1d‐ependent adhesion in t cell‐mediated cytotoxicity

  1988cited by this paper
• Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines.

  1988cited by this paper
• Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon.

  1987cited by this paper
• Lymphocyte function-associated antigen 1 (LFA-1) and natural killer (NK) cell activity: LFA-1 is not necessary for all killer: target cell interactions.

  1987cited by this paper
• A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.

  1986cited by this paper
• Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones

  1986cited by this paper
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

  1984cited by this paper
• Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

  1982cited by this paper
• Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

  1978cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Cleavage of structural proteins during

  1970cited by this paper

• Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma

  2025cites this paper
• Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion

  2025cites this paper
• The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets

  2025cites this paper
• Universal protection of allogeneic T-cell therapies from natural killer cells via CD300a agonism

  2024cites this paper
• Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors

  2024cites this paper
• Hodgkin Lymphoma: A Special Microenvironment

  2021influential citation
• Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma

  2021cites this paper
• Intercellular adhesion molecule-1

  2020cites this paper
• EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas.

  2020cites this paper
• Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells

  2019cites this paper
• A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies

  2018influential citation
• CD38 contributes to human natural killer cell responses through a role in immune synapse formation

  2018cites this paper
• Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy

  2018cites this paper
• Adhesion in Physiological, Benign and Malignant Proliferative States of the Endometrium: Microenvironment and the Clinical Big Picture

  2018cites this paper
• Genetic background and evolution of relapses in aggressive B-cell lymphomas

  2017cites this paper
• Leishmania donovani resistant to Ambisome or Miltefosine exacerbates CD58 expression on NK cells and promotes trans‐membrane migration in association with CD2

  2017cites this paper
• Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma

  2017cites this paper
• Analyse genetischer Läsionen im Hodgkin-Lymphom und einem Kombinationslymphom sowie Charakterisierung humaner CD30-positiver B-Zellen

  2015cites this paper
• Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

  2015cites this paper
• Alterations of the CD58 gene in classical Hodgkin lymphoma

  2015cites this paper
• Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.

  2014cites this paper
• Prognostic prediction and diagnostic role of intercellular adhesion molecule-1 (ICAM1) expression in clear cell renal cell carcinoma

  2014cites this paper
• Granulomatosis with Polyangiitis Cells: Implications for the Pathophysiology of Cells Show Distinct Capacity To Activate NK Tissue-Specific Microvascular Endothelial

  2014cites this paper
• Tissue-Specific Microvascular Endothelial Cells Show Distinct Capacity To Activate NK Cells: Implications for the Pathophysiology of Granulomatosis with Polyangiitis

  2014cites this paper
• Molecular characterization of chronic-type adult T-cell leukemia/lymphoma.

  2014cites this paper
• Failure of immunological cells to eradicate tumor and cancer cells: an overview

  2014cites this paper
• Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.

  2014cites this paper
• Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells

  2013cites this paper
• Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide

  2013cites this paper
• Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.

  2012cites this paper
• Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients

  2012cites this paper
• Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule‐1

  2012cites this paper
• An organ system based approach to prognosis in advanced melanoma.

  2012cites this paper
• Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients

  2011cites this paper
• Effects of interferon- y (IFN- y) and tumor necrosis factor-a (TNF-a') on adhesion and lysis by lymphokine-activated killer (LAK) cells of squamous cell carcinoma cells: Participation of cell-adhesion molecules on tumor cells

  2011cites this paper
• Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.

  2011cites this paper
• An extended antibody microarray for surface profiling metastatic melanoma.

  2010cites this paper
• Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma

  2010cites this paper
• CD40 Expression by Human Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting With the Therapeutic Anti-CD40 Antibody CP-870,893

  2010cites this paper
• Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

  2009influential citation
• Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2′-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications

  2007cites this paper
• Down-regulation of zeta chain and zeta-associated protein 70 (Zap 70) expression in circulating T lymphocytes in laryngeal squamous cell carcinoma.

  2007cites this paper
• Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications

  2006cites this paper
• The Coincidence of Chromosome 15 Aberrations and β2-Microglobulin Gene Mutations Is Causative for the Total Loss of Human Leukocyte Antigen Class I Expression in Melanoma

  2006cites this paper
• Monoclonal Antibodies Targeted Against Melanoma and Ovarian Tumors Enhance Dendritic Cell-Mediated Cross-Presentation of Tumor-Associated Antigens and Efficiently Cross-Prime CD8+ T Cells

  2006cites this paper
• Heterodimeric Retinoic Acid Receptor-li and Retinoid X Receptor-of Complexes Stimulate Expression of the Intercellular Adhesion Molecule-i Gene1

  2005cites this paper
• Roles of Immune-Cell-Derived Matrix Metalloproteinases in Tumor Growth and Metastasis

  2005cites this paper
• Regulation of Intercellular Adhesion Molecule-I Gene by Tumor Necrosis Factor-a Is Mediated by the Nuclear Factor-KB Heterodimers p 65 / p 65 and p 65 / c-Rel in the Absence of p 501

  2005cites this paper
• Origin of Anti-Tumor Immunity Failure in Mammals

  2004cites this paper
• Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine

  2004cites this paper
• ICAM‐1 and β3 integrin immunoexpression in malignant melanoma cells: can they be used as additional predictors?

  2003cites this paper
• Epigenetic targets for immune intervention in human malignancies

  2003cites this paper
• The influence of tobacco smoking on adhesion molecule profiles

  2002cites this paper
• Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells

  2002cites this paper
• ADAPTATION OF COMMERCIAL IMMUNOASSAYS TO ANALYSIS OF COMPLEX BIOLOGICAL SUBSTANCES

  2002cites this paper
• Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression.

  2002cites this paper
• 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.

  2002cites this paper
• Targeting of liposomes to melanoma cells with high levels of ICAM-1 expression through adhesive peptides from immunoglobulin domains.

  2002cites this paper
• Biology of Natural Killer Cells in Cancer and Infection

  2002cites this paper
• Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity

  2002cites this paper
• Promoter Methylation Controls the Expression of MAGE2, 3 and 4 Genes in Human Cutaneous Melanoma

  2002cites this paper
• Escape Mechanisms in Tumour Immunity

  2001cites this paper
• The Biology of Natural Killer Cells and Implications for Therapy of Human Disease

  2001cites this paper
• Unbalanced expression of HLA‐A and ‐B antigens: A specific feature of cutaneous melanoma and other non‐hemopoietic malignancies reverted by IFN‐γ

  2001cites this paper
• Soluble ICAM-1 in breast cancer: clinical significance and biological implications

  2001cites this paper
• Suppression of Natural Killer Cell Function and Production of Soluble ICAM‐1: Endometrial Stroma Versus Melanoma

  2001cites this paper
• Immune-gene therapy for renal cancer: chimeric receptor-mediated lysis of tumor cells

  2001cites this paper
• Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro.

  2000cites this paper
• Escape mechanisms in tumor immunity: a year 2000 update.

  2000cites this paper
• Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

  2000cites this paper
• From the Study of Tumor Cell Immunogenicity to the Generation of Antitumor Cytotoxic Cells in Non-Hodgkin's Lymphomas

  2000cites this paper
• α-Melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro

  2000cites this paper
• Migration-Associated Adhesion Molecules in Squamous Cell Carcinomas of the Head and Neck

  2000cites this paper
• NK binding capacity and lytic activity depend on the expression of ICAM-1 on target bone tumours.

  1999cites this paper
• Serum levels of leukocyte functional antigen‐3 in pregnancy and preeclampsia

  1999cites this paper
• In vitro analysis of the melanoma/endothelium interaction increasing the release of soluble intercellular adhesion molecule 1 by endothelial cells

  1999cites this paper
• The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid

  1999cites this paper
• P0 protein mediated targeting of liposomes to melanoma cells with high level of ICAM-1 expression.

  1999cites this paper
• Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR).

  1999cites this paper
• Pentoxifylline-induced modulation of melanoma cell growth, adhesion and lymphokine activated killer cell-mediated lysis.

  1999cites this paper
• Expression of ICAM-1 During IFN-alpha-Based Treatment of Metastatic Malignant Melanoma: Relation to Tumor-Infiltrating Mononuclear Cells and Regressive Tumor Changes

  1999cites this paper
• Soluble ICAM‐1 seems to be related to prognosis in malignant melanoma

  1999cites this paper
• Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.

  1999cites this paper
• Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patients.

  1998cites this paper
• Simultaneous measurement of circulating intercellular adhesion molecule-1 and serum copper zinc superoxide dismutase activity in patients with malignant melanoma.

  1998cites this paper
• Molecular biology of human melanoma development and progression

  1998cites this paper
• LFA‐3 co‐stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR‐independent activation signal

  1998cites this paper
• Prognostic significance of soluble Fas in the serum of patients with bladder cancer.

  1998cites this paper
• Intercellular Adhesion Molecule-1 Is Upregulated via the Protein Kinase C Pathway in Human Thyroid Carcinoma Cell Lines

  1998cites this paper
• Die Bedeutung von ICAM-1 auf die Lyse von humanen Pankreaskarzinomzellen durch autologe, zytotoxische T-Lymphozyten

  1998cites this paper
• Stromal reaction in cancer tissue: Pathophysiologic significance of the expression of matrix‐degrading enzymes in relation to matrix turnover and immune/inflammatory reactions

  1998cites this paper
• Chimeric scFv/γ receptor‐mediated T‐cell lysis of tumor cells is coregulated by adhesion and accessory molecules

  1998cites this paper
• Retinoid and pentoxifylline-induced modulation of human melanoma cell metastasis.

  1998cites this paper
• Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.

  1998cites this paper
• Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators.

  1998cites this paper
• Escape from host-antitumor immunity.

  1997cites this paper
• Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.

  1997cites this paper
• Serum levels of intercellular adhesion molecule-1 in squamous cell carcinoma of the head and neck.

  1997cites this paper
• Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.

  1997cites this paper
• Mechanisms of metastasis.

  1997cites this paper